Thyroid C-cell Tumors: In rodent reports, semaglutide has actually been shown to trigger thyroid C-mobile tumors. It can be unidentified whether this threat applies to humans, but semaglutide is contraindicated in sufferers with a personal or family heritage of medullary thyroid carcinoma (MTC) or people with A number of Endocrine Neoplasia syndrom